Overview

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors
Phase:
Phase 4
Details
Lead Sponsor:
The Chaim Sheba Medical Center
Treatments:
Methylphenidate
Risperidone